Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Availability and payer coverage of BRCA1/2 tests and gene panels.

Nature biotechnology - 1 Sept 2015

Clain Elizabeth, Trosman Julia R, Douglas Michael P, Weldon Christine B, Phillips Kathryn A

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to BRCA1 Protein
Share to BRCA2 Protein
Share to Health Services Accessibility

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to High-Throughput Screening Assays

Share to Multigene Family

Share to Neoplasms

Share to United States

Source

Open in PubMed Open full text

Identifiers

PMID: 26348951
DOI: 10.1038/nbt.3322
PMCID: PMC4625918

Genes

BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Availability and payer coverage of BRCA1/2 tests and gene panels.PMID 26348951Read ↗

Experts say more women should be tested for BRCA1 and BRCA2 genetic mutations.Semantic proximity Read ↗

BRCA1 and BRCA2: to test or not to test.Semantic proximity Read ↗

Increasing the Uptake of Cancer Risk Management Strategies for Women With BRCA1/2 Sequence Variations.Semantic proximity Read ↗

When, how and why BRCA1 and BRCA2 genetic testing is offered to patients who do not meet standard criteriaSemantic proximity Read ↗

The Role of Race and Insurance Status in Access to Genetic Counseling and Testing Among High-Risk Breast Cancer PatientsSemantic proximity Read ↗

Real-world multi-country study of BRCA1/2 mutation testing among adult women with HER2-negative advanced breast cancer.Semantic proximity Read ↗

Pros and cons of screening for BRCA mutations.Semantic proximity Read ↗

Points to consider: is there evidence to support BRCA1/2 and other inherited breast cancer genetic testing for all breast cancer patients? A statement of the American College of Medical Genetics and Genomics (ACMG).Semantic proximity Read ↗

The role of testing for BRCA1 and BRCA2 mutations in cancer prevention.Semantic proximity Read ↗

Testing for BRCA1/2 Mutations.Semantic proximity Read ↗

Recommendations for the implementation of BRCA testing in the care and treatment pathways of ovarian cancer patients.Semantic proximity Read ↗

Cost-effectiveness of Universal BRCA1/2 Screening: Evidence-Based Decision Making.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.